本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AEON Biopharma

1.16
+0.160016.00%
盤後1.10-0.0598-5.16%19:35 EDT
成交量:29.94萬
成交額:34.30萬
市值:1,404.28萬
市盈率:0.24
高:1.33
開:0.9801
低:0.9800
收:1.00
52周最高:1.45
52周最低:0.3750
股本:1,210.59萬
流通股本:865.85萬
量比:3.54
換手率:3.46%
股息:- -
股息率:- -
每股收益(TTM):4.87
每股收益(LYR):72.93
淨資產收益率:--
總資產收益率:-165.52%
市淨率:-0.71
市盈率(LYR):0.02

資料載入中...

2024/07/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/09

SEC問詢函

Form CORRESP - Correspondence
2024/07/09

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/31

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/31

SEC問詢函

Form CORRESP - Correspondence
2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/14

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/19

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933